Comparative Pharmacology
Head-to-head clinical analysis: CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE versus WYAMINE SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE versus WYAMINE SULFATE.
CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE vs WYAMINE SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cetirizine is a second-generation antihistamine that selectively inhibits peripheral H1 receptors, reducing histamine-mediated allergic responses. Pseudoephedrine is a sympathomimetic amine that acts as an alpha-adrenergic agonist, causing vasoconstriction and decongestion of nasal mucosa.
Wyamine sulfate (mephentermine sulfate) is a sympathomimetic amine that acts primarily by releasing norepinephrine from presynaptic nerve terminals, with direct alpha- and beta-adrenergic receptor agonist activity. It causes vasoconstriction and positive inotropic effects, increasing cardiac output and blood pressure.
1 tablet (5 mg cetirizine / 120 mg pseudoephedrine) orally every 12 hours; maximum 2 tablets per day.
Intramuscular injection: 15-30 mg as a single dose; may repeat in 10-15 minutes if needed. Maximum total dose: 60 mg.
None Documented
None Documented
Cetirizine: terminal half-life ~8.3 hours in healthy adults (prolonged to 20-30 hours in renal impairment). Pseudoephedrine: terminal half-life ~4-8 hours (pH-dependent urinary excretion; prolonged in alkaline urine).
Terminal elimination half-life is 6-8 hours in adults with normal renal function (CrCl >90 mL/min).
Cetirizine: approximately 70% excreted unchanged in urine via glomerular filtration and tubular secretion; about 10% in feces. Pseudoephedrine: 70-90% excreted unchanged in urine; remainder as inactive metabolites.
Primarily renal; 90% excreted unchanged in urine within 24 hours. Minimal biliary/fecal elimination (<5%).
Category A/B
Category C
Sympathomimetic
Sympathomimetic